Leading global healthcare distributor
Henry Schein Inc.
) recently expanded its dental distribution business in the U.S.
The company's U.S. dental franchise Henry Schein Dental entered a
distribution partnership with Carl Zeiss Meditec Inc. to
distribute the well-regarded portfolio of ZEISS dental
microscopes and loupes.
ALIGN TECH INC (ALGN): Free Stock Analysis
HENRY SCHEIN IN (HSIC): Free Stock Analysis
PATTERSON COS (PDCO): Free Stock Analysis
SIRONA DENTAL (SIRO): Free Stock Analysis
To read this article on Zacks.com click here.
The distribution partnership applies to OPMI pico and OPMI
PROergo, and for ZEISS EyeMag dental loupes. As per the
agreement, effective Jul 1, 2013, Henry Schein will supply
technically advanced line of ZEISS dental products to dentists
and endodontists in the U.S.
The partnership between Henry Schein and the Medical Technology
division of ZEISS will improve standard of patient care. This
will be achieved on the back of inclusion of premium dental
equipments in Henry Schein's line of dental product and services
available to office-based dental practitioners.
The exceptional visualization and superior scientific design of
ZEISS products will improve working and operating comfort for
dental professionals in the U.S. The deal underlines Henry
Schein's strategy to include innovative and patient-centric
dental equipment in its dental supply portfolio. Thus, the novel
distribution partnership should expand the company's dental
business in the domestic market.
Henry Schein's focus on its core dental business is encouraging.
We are upbeat about this new distribution partnership as it
leverages the companies' revenue profile in the dental market. We
expect sales to benefit from ZEISS dental equipment sales in the
However, Henry Schein should be aware of similar advances made by
peers in the industry. Recently,
Patterson Companies Inc.
) inked a strategic distribution agreement with
Sirona Dental Systems Inc.
). Henry Schein needs to take note of moves made by such strong
HSIC currently retains a Zacks Rank #3 (Hold). While we remain on
the sidelines for this healthcare distributor, we believe that
Align Technology Inc.
), carrying a Zacks Rank #2 (Buy), is worth considering.